Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting

NCT06324734 · clinicaltrials.gov ↗

COMPLETED

Status

2506

Enrollment

INDUSTRY

Sponsor class

Conditions

Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE

Sponsor

AstraZeneca